Jin-Zhou Zhu

Jin-Zhou Zhu

Auto-generated profile, based on publicly available information

Jin-Zhou Zhu

Department of Gastroenterology, The First Affiliated Hospital of Soochow University, Suzhou, China

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 May 2015 in Digestive Diseases and Sciences
Verified
Journal Article
Closed access
PDF file
JZJin-Zhou Zhu
Jin-Zhou Zhu
DYDai Yining
Dai Yining
YWYu-Ming Wang
Yu-Ming Wang
QZQin-Yi Zhou
Qin-Yi Zhou
CYChao-Hui Yu
Chao-Hui Yu
YLYou-Ming Li
You-Ming Li

18 June 2014 in Alimentary Pharmacology & Therapeutics
Verified
Journal Article
Closed access
PDF file
JZJ.‐Z. Zhu
J.‐Z. Zhu
YWY.‐M. Wang
Y.‐M. Wang
QZQ.‐Y. Zhou
Q.‐Y. Zhou
KZK.‐F. Zhu
K.‐F. Zhu
CYC.‐H. Yu
C.‐H. Yu
YLY.‐M. Li
Y.‐M. Li

1 January 2015 in World Journal of Gastroenterology
Verified
Journal Article
Open access
JZJin-Zhou Zhu
Jin-Zhou Zhu
QZQin-Yi Zhou
Qin-Yi Zhou
YWYu-Ming Wang
Yu-Ming Wang
YDYi-Ning Dai
Yi-Ning Dai
JZJiang Zhu
Jiang Zhu
YLYou-Ming Li
You-Ming Li
AIM: To investigate the relationship between the economy and the adult prevalence of fatty liver disease (FLD) in mainland China. METHODS: Literature searches on the PubMed and Chinese National Knowledge Infrastructure databases were performed to identify eligible studies published before July 2014. Records were limited to cross-sectional surveys or baseline surveys of longitudinal studies that reported the adult prevalence of FLD and recruited subjects from the general population or community. The gross domestic product (GDP) per capita was chosen to assess the economic status. Multiple linear regression and Loess regression were chosen to fit the data and calculate the 95%CIs. Fitting and overfitting of the models were considered in choosing the appropriate models. RESULTS: There were 27 population-based surveys from 26 articles included in this study. The pooled mean prevalence of FLD in China was 16.73% (95%CI: 13.92%-19.53%). The prevalence of FLD was correlated with the GDP per capita and survey years in the country (adjusted R2 = 0.8736, PGDP per capita = 0.00426, Pyears = 0.0000394), as well as in coastal areas (R2 = 0.9196, PGDP per capita = 0.00241, Pyears = 0.00281). Furthermore, males [19.28% (95%CI: 15.68%-22.88%)] presented a higher prevalence than females [14.1% (95%CI: 11.42%-16.61%), P = 0.0071], especially in coastal areas [21.82 (95%CI: 17.94%-25.71%) vs 17.01% (95%CI: 14.30%-19.89%), P = 0.0157]. Finally, the prevalence was predicted to reach 20.21% in 2020, increasing at a rate of 0.594% per year. CONCLUSION: This study reveals a correlation between the economy and the prevalence of FLD in mainland China.

17 June 2015 in Cancer Causes & Control
Verified
Journal Article
Closed access
PDF file
YDYi-Ning Dai
Yi-Ning Dai
JWJing-Hua Wang
Jing-Hua Wang
JZJin-Zhou Zhu
Jin-Zhou Zhu
JLJie-Qiong Lin
Jie-Qiong Lin
CYChao-Hui Yu
Chao-Hui Yu
YLYou-Ming Li
You-Ming Li

15 September 2020 in Experimental and Clinical Endocrinology & Diabetes
Verified
Journal Article
Closed access
PDF file
XMXiaoming Ma
Xiaoming Ma
XXXing Xue
Xing Xue
JZJingxin Zhang
Jingxin Zhang
SLShuang Liang
Shuang Liang
CXChunfang Xu
Chunfang Xu
JZJinzhou Zhu
Jinzhou Zhu
Background and Aims Liver expressed antimicrobial peptide 2 (LEAP2) is recently identified as a regulator in energy metabolism. This study aims to 1) investigate the role of leap2 in hepatic steatosis in C57BL/6 mice; 2) evaluate the association between circulating LEAP2 levels and liver fat contents in a hospital based case-control study. Methods The rodent experiment: western blotting and qPCR were performed to evaluate leap2 levels, lipid metabolism pathways and insulin signaling. shRNA was used to knockdown leap2. The clinical study: commercial ELISA kits were used to measure circulating LEAP2 levels (validated by western blotting). Liver fat content was estimated using MRI-derived proton density fat fraction and FibroScan-derived controlled attenuation parameter. Results The rodent experiment found the hepatic expression and secreted levels of leap2 were increased in mice with diet-induced steatosis. Leap2 knockdown ameliorated steatosis via lipolytic/lipogenic pathway and improved insulin sensitivity via IRS/AKT signaling. The clinical study reported increased circulating levels of LEAP2 in the subjects with steatosis. Moreover, LEAP2 correlated positively with age, body mass index, waist-to-hip ratio, liver fat content, fasting insulin and HOMA-IR, whereas inversely with acyl-ghrelin. Furthermore, the circulating levels of LEAP2 are dependent on liver fat content, acyl-ghrelin and fasting glucose. Lastly, circulating LEAP2 is an independent predictor of NAFLD. Conclusions The study suggests LEAP2 is associated with hepatic steatosis, which may involve lipolytic/lipogenic pathway and insulin signaling.

23 December 2013 in Acta Pharmacologica Sinica
Verified
Journal Article
Closed access
TLTing-Ting Li
Ting-Ting Li
JZJian-Fu Zhang
Jian-Fu Zhang
SFSu-Juan Fei
Su-Juan Fei
SZSheng-Ping Zhu
Sheng-Ping Zhu
JZJin-Zhou Zhu
Jin-Zhou Zhu
ZLZhang-Bo Liu
Zhang-Bo Liu